Frank M La Duca

Title: Frank M La Duca: Innovator in Hematology Testing

Introduction

Frank M La Duca is a notable inventor based in East Brunswick, NJ (US). He has made significant contributions to the field of hematology through his innovative patents. With a total of 2 patents, La Duca has focused on improving blood testing methods that enhance clinical practices.

Latest Patents

La Duca's latest patents include a Whole Blood Activated Partial Thromboplastin Time Test and a Method for Clotting Heparized Blood by the Addition of Protamine. The APTT test he developed does not require blood that has been anticoagulated with citrate. This advancement allows for the combination of the citrate anticoagulant step with the contact activation step, enabling the use of fresh non-anticoagulated blood specimens for direct APTT testing. His second patent involves a cocktail reagent preparation for the rapid production of serum, which contains thrombin, snake venom, and protamine sulfate. This preparation utilizes very small quantities of clot-promoting substances that work synergistically to achieve rapid clotting of highly heparinized blood without altering the chemical analysis of blood enzymes, proteins, sugars, or electrolytes.

Career Highlights

Frank M La Duca is associated with the International Technidyne Corporation, where he has applied his expertise in developing innovative medical testing solutions. His work has significantly impacted the ability of clinicians to monitor organ and tissue function more closely, allowing for better patient therapy adjustments.

Collaborations

La Duca has collaborated with Eduardo I Marcelino, contributing to advancements in the field of hematology.

Conclusion

Frank M La Duca's contributions to blood testing innovations have paved the way for improved clinical practices. His patents reflect a commitment to enhancing patient care through scientific advancements.